These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19174123)

  • 1. [Update on new insulins].
    Tapia Ceballos L
    An Pediatr (Barc); 2009 Jan; 70(1):65-71. PubMed ID: 19174123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin analog preparations and their use in children and adolescents with type 1 diabetes mellitus.
    Miles HL; Acerini CL
    Paediatr Drugs; 2008; 10(3):163-76. PubMed ID: 18454569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin glargine: long-acting basal insulin analog for improved metabolic control.
    Gerich JE
    Curr Med Res Opin; 2004 Jan; 20(1):31-7. PubMed ID: 14741069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic advantages of insulin analogues and premixed insulin analogues over human insulins: impact on efficacy and safety.
    Rolla A
    Am J Med; 2008 Jun; 121(6 Suppl):S9-S19. PubMed ID: 18514090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin detemir: new drug. A second long-acting insulin analogue: many uncertainties, few advantages.
    Prescrire Int; 2006 Oct; 15(85):163-7. PubMed ID: 17121210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically engineered insulin analogs: diabetes in the new millenium.
    Vajo Z; Duckworth WC
    Pharmacol Rev; 2000 Mar; 52(1):1-9. PubMed ID: 10699152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The new insulins].
    Krzentowski G
    Rev Med Brux; 2005 Sep; 26(4):S241-5. PubMed ID: 16240869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn therapy for newly diagnosed type 1 diabetes.
    Al Shamsi AM
    Pediatrics; 2008 Sep; 122(3):675-6; author reply 676. PubMed ID: 18762540
    [No Abstract]   [Full Text] [Related]  

  • 11. Type 1 diabetes mellitus: effective insulin strategies with less hypoglycemia.
    Bolli GB
    Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):13-20. PubMed ID: 19667675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the treatment of diabetes-insulin analogues.
    Vajo Z; Duckworth WC
    Minerva Endocrinol; 2002 Sep; 27(3):167-80. PubMed ID: 12091792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin analogs and pregnancy: an update.
    Torlone E; Di Cianni G; Mannino D; Lapolla A
    Acta Diabetol; 2009 Sep; 46(3):163-72. PubMed ID: 19572099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin analogues: an example of applied medical science.
    Sheldon B; Russell-Jones D; Wright J
    Diabetes Obes Metab; 2009 Jan; 11(1):5-19. PubMed ID: 19120431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin analogues for type 1 diabetes in children and adolescents.
    Galli-Tsinopoulou A; Stergidou D
    Drugs Today (Barc); 2012 Dec; 48(12):795-809. PubMed ID: 23243636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quest for physiologic insulin replacement.
    Owens DR
    Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):4-12. PubMed ID: 19667674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs.
    Mollar-Puchades MA; Villanueva IL
    Diabetes Res Clin Pract; 2009 Jan; 83(1):e21-2. PubMed ID: 19070911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin therapy in diabetes mellitus: how can the currently available injectable insulins be most prudently and efficaciously utilised?
    Bell DS
    Drugs; 2007; 67(13):1813-27. PubMed ID: 17722952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin detemir is characterized by a more reproducible pharmacokinetic profile than insulin glargine in children and adolescents with type 1 diabetes: results from a randomized, double-blind, controlled trial.
    Danne T; Datz N; Endahl L; Haahr H; Nestoris C; Westergaard L; Fjording MS; Kordonouri O
    Pediatr Diabetes; 2008 Dec; 9(6):554-60. PubMed ID: 18761644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perinatal outcomes in pregnancies managed with antenatal insulin glargine.
    Egerman RS; Ramsey RD; Kao LW; Bringman JJ; Haerian H; Kao JL; Bush AJ
    Am J Perinatol; 2009 Sep; 26(8):591-5. PubMed ID: 19370512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.